Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin and reboxetine for therapy-resistant enuresis
2008-002636-15Phase 2Completed
- Sponsor
- Uppsala University Children’s Hospital
- Start
- Feb 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of desmopressin and reboxetine in nocturnal enuresis (NE) and enuresis (4 arms), sponsored by Uppsala University Children’s Hospital. Primary endpoint: Reduction in wet nights. Started Feb 2009; status: completed.
02
Drugs
desmopressinreboxetine
03
Conditions
nocturnal enuresis (NE)enuresis
Beyond the preview
Go deeper on 2008-002636-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002636-15.